Published in J Bone Miner Res on August 01, 1998
Milk intake and risk of mortality and fractures in women and men: cohort studies. BMJ (2014) 6.87
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int (2004) 2.62
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Pitfalls in the external validation of FRAX. Osteoporos Int (2011) 2.21
Common variants in the region around Osterix are associated with bone mineral density and growth in childhood. Hum Mol Genet (2009) 1.99
The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design. Osteoporos Int (2009) 1.85
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int (2006) 1.52
BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res (2011) 1.51
Leisure physical activity and the risk of fracture in men. PLoS Med (2007) 1.41
The human cost of fracture. Osteoporos Int (2005) 1.33
Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women. Osteoporos Int (2006) 1.26
Does a history of non-vertebral fracture identify women without osteoporosis for treatment? J Gen Intern Med (2008) 1.23
Epidemiology of hip and wrist fractures in Cameroon, Africa. Osteoporos Int (2003) 1.11
A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int (2006) 1.07
Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study. BMJ (2010) 1.05
What accounts for rib fractures in older adults? J Osteoporos (2011) 1.00
Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2010) 0.93
Urban-rural differences in distal forearm fractures: Cohort Norway. Osteoporos Int (2007) 0.89
Bone material strength is associated with areal BMD but not with prevalent fractures in older women. Osteoporos Int (2015) 0.89
Fracture risk in diabetic elderly men: the MrOS study. Diabetologia (2014) 0.88
Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance. Osteoporos Int (2010) 0.87
Influence of hysterectomy on long-term fracture risk. Fertil Steril (2007) 0.86
Osteoporotic fractures and heart failure in the community. Am J Med (2011) 0.85
Coffee consumption and risk of fractures: a meta-analysis. Arch Med Sci (2012) 0.84
The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res (2012) 0.83
Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS). J Bone Miner Res (2016) 0.82
Barriers to effective management of osteoporosis in moderate and minimal trauma fractures: a prospective study. Osteoporos Int (2004) 0.82
Single-point assessment of warfarin use and risk of osteoporosis in elderly men. J Am Geriatr Soc (2008) 0.82
Burden of traumatic spine fractures in Tehran, Iran. BMC Public Health (2011) 0.81
Predictive values of calcaneal quantitative ultrasound and dual energy X ray absorptiometry for non-vertebral fracture in older men: results from the MrOS study (Hong Kong). Osteoporos Int (2011) 0.81
American Society of Biomechanics Journal of Biomechanics Award 2013: cortical bone tissue mechanical quality and biological mechanisms possibly underlying atypical fractures. J Biomech (2015) 0.80
Anemia and the risk of non-vertebral fractures: the Tromsø Study. Osteoporos Int (2009) 0.80
Polyalanine repeat polymorphism in RUNX2 is associated with site-specific fracture in post-menopausal females. PLoS One (2013) 0.80
Non-linear relationship between serum 25-hydroxyvitamin D concentration and subsequent hip fracture. Osteoporos Int (2012) 0.79
Coffee consumption and risk of fracture in the Cohort of Swedish Men (COSM). PLoS One (2014) 0.78
Potential Extensions of the US FRAX Algorithm. J Osteoporos (2012) 0.78
More-than-minimal-trauma fractures are associated with low bone density: an 8-year prospective study. Osteoporos Int (2016) 0.77
Non-hip and non-vertebral fractures: the neglected fracture sites. Osteoporos Int (2015) 0.76
Risk factors for fracture in middle-age and older-age men of African descent. J Bone Miner Res (2014) 0.76
The Impact of Fracture Incidence on Health Related Quality of Life among Community-Based Postmenopausal Women. J Osteoporos (2015) 0.76
BONE FRAGILITY, FRACTURE RISK AND TRAUMA:A COMPLICATED TRIANGLE IN CHILDREN. Acta Ortop Bras (2017) 0.75
Update in women's health. J Gen Intern Med (2009) 0.75
Relationship between Decrease in Serum Sodium Level and Bone Mineral Density in Osteoporotic Fracture Patients. J Bone Metab (2015) 0.75
Olecranon Fractures Have Features of Osteoporotic Fracture. J Bone Metab (2017) 0.75
Does recalled dieting increase the risk of non-vertebral osteoporotic fractures? The Tromsø Study. Osteoporos Int (2012) 0.75
Opportunistic screening for osteoporosis by routine CT in Southern Europe. Osteoporos Int (2017) 0.75
Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis. Nat Genet (2017) 0.75
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev (1999) 7.69
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest (1999) 7.66
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Therapeutic approaches to bone diseases. Science (2000) 5.60
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone (2004) 5.27
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
Osteoblastic cells are involved in osteoclast formation. Endocrinology (1988) 4.37
Modulation of osteoclast differentiation. Endocr Rev (1992) 4.27
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int (1981) 3.77
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab (2005) 3.67
Exercise during growth and bone mineral density and fractures in old age. Lancet (2000) 3.06
A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology (1989) 2.83
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA (1997) 2.46
The bone density of female twins discordant for tobacco use. N Engl J Med (1994) 2.44
Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone (2002) 2.40
The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med (1984) 2.33
Malignant glaucoma after laser iridotomy. Ophthalmology (1992) 2.28
Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun (1999) 2.28
Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res (1991) 2.26
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology (1999) 2.11
Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease. Endocr Rev (2006) 2.08
Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab (2001) 2.08
The hypercalcemia of malignancy: pathogenesis and management. Metabolism (1982) 2.01
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med (1996) 2.00
Risk factors for spinal osteoporosis in men. Am J Med (1983) 2.00
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinology (2001) 1.98
An unusual case of Marine-Lenhart syndrome. Thyroid (2003) 1.97
The effect of mechanical loading on the size and shape of bone in pre-, peri-, and postpubertal girls: a study in tennis players. J Bone Miner Res (2002) 1.95
Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol (2002) 1.93
Moderate exercise during growth in prepubertal boys: changes in bone mass, size, volumetric density, and bone strength: a controlled prospective study. J Bone Miner Res (1998) 1.88
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol (1996) 1.79
Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res (1998) 1.77
Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology (1998) 1.75
The association between socioeconomic status and osteoporotic fracture in population-based adults: a systematic review. Osteoporos Int (2008) 1.75
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology (1998) 1.75
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest (1986) 1.73
Effects of parathyroid hormone on Wnt signaling pathway in bone. J Cell Biochem (2005) 1.71
Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int (1999) 1.69
Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone (1999) 1.66
The general practice care of people with intellectual disability: barriers and solutions. J Intellect Disabil Res (1997) 1.66
Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology (2001) 1.66
Health burden of hip and other fractures in Australia beyond 2000. Projections based on the Geelong Osteoporosis Study. Med J Aust (1999) 1.62
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res (1990) 1.61
Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors. J Exp Med (1995) 1.60
Body fat distribution and non-insulin-dependent diabetes: comparison of a fiber-rich, high-carbohydrate, low-fat (23%) diet and a 35% fat diet high in monounsaturated fat. Am J Clin Nutr (1996) 1.60
The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. Br J Rheumatol (1998) 1.59
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest (1993) 1.58
Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. Cancer Res (1990) 1.54
Tumor-derived growth factor increases bone resorption in a tumor associated with humoral hypercalcemia of malignancy. Science (1983) 1.52
The population burden of fractures originates in women with osteopenia, not osteoporosis. Osteoporos Int (2006) 1.52
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol (2001) 1.52
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest (1982) 1.48
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res (2001) 1.47
Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis? J Bone Joint Surg Br (1981) 1.46
Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia. Lancet (1993) 1.45
The biomechanical basis of vertebral body fragility in men and women. J Bone Miner Res (2001) 1.45
Oral contraceptives and bone mineral density: A population-based study. Am J Obstet Gynecol (2000) 1.42
Short stature and delayed puberty in gymnasts: influence of selection bias on leg length and the duration of training on trunk length. J Pediatr (2000) 1.41
Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int (2000) 1.41
Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res (1983) 1.38
Calcitonin gene-related peptide stimulates cyclic AMP formation in rat aortic smooth muscle cells. Biochem Biophys Res Commun (1985) 1.38
Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum (2000) 1.37
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther (1999) 1.35
Fracture rates lower in rural than urban communities: the Geelong Osteoporosis Study. J Epidemiol Community Health (2002) 1.34
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33